George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures
Târgu Mureş, Mureș County, 540142, Romania
NCT Number: NCT07551830
This observational study investigates differences in psychological processes and emotional symptoms between individuals with Alcohol Use Disorder (AUD) and a non-clinical control group. PBAT, PHQ-9, and GAD-7 will be used. MANCOVA will test group differences controlling for demographics.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Târgu Mureş, Mureș County, 540142, Romania
The present study is grounded in the process-based approach to psychopathology, which emphasizes the identification and modification of core psychological processes underlying mental disorders, rather than focusing exclusively on categorical diagnoses.
A central theoretical framework guiding this approach is the Extended Evolutionary Meta-Model (EEMM), which conceptualizes psychological functioning and psychopathology through evolutionary principles:
According to this model, psychopathology (including Alcohol Use Disorder) is characterized by psychological inflexibility, maladaptive behavioral selection, and poor retention of functional strategies, often in interaction with contextual insensitivity.
These processes operate across multiple domains, including affect, cognition, attention, motivation, self, and overt behavior.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: After enrollment (single time point).
The scale involves the depiction of psychological and behavioral processes involved in adaptation and maladaptation, according to the Extended Evolutionary Meta-Model.
The scale includes 18 items, each involving a stand-alone, individual score, indicating the degree to which the responder engages in the specific process. The scale comprises both positive and negative behavioral strategies.
Time frame: After enrollment (single time point).
The scale involves the assessment of depressive symptoms, with a score range between 0 and 27. Scores between 5 and 9 mean mild depression, 10 to 14 moderate depression, 15 to 19 moderate to severe depression and above 20 severe depression (Kroenke et al., 2001).
Time frame: After enrollment (single time point).
The scale involves the assessment of anxiety symptoms, with a score range from 0 to 21. Scores between 5 and 9 indicate mild anxiety, scores between 10 and 14 moderate anxiety, while those above 15 show severe anxiety.
Contact information is provided by the study sponsor or research team.
Cristiana M. Cojocaru, Lecturer
CONTACT
Octavian C. Popa, Assoc.Prof.
CONTACT
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Other
Acronym: PBAT Addiction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07279363
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Rochester, New York, United States
View Trial DetailsNCT07405606
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT07571226
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Beijing, China
View Trial DetailsNCT06835907
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Jette, Brussels Capital, Belgium
View Trial Details